First American Bank Sells 1,996 Shares of Synopsys, Inc. $SNPS

First American Bank trimmed its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 44.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,447 shares of the semiconductor company’s stock after selling 1,996 shares during the quarter. First American Bank’s holdings in Synopsys were worth $1,207,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Lionshead Wealth Management LLC increased its stake in Synopsys by 1.9% in the 2nd quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after acquiring an additional 17 shares during the last quarter. YANKCOM Partnership increased its position in Synopsys by 3.3% in the second quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after purchasing an additional 17 shares during the last quarter. Manchester Capital Management LLC raised its stake in Synopsys by 5.3% during the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 17 shares in the last quarter. Hemington Wealth Management lifted its position in Synopsys by 10.1% during the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after purchasing an additional 18 shares during the last quarter. Finally, Concord Asset Management LLC VA grew its stake in shares of Synopsys by 0.8% in the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after buying an additional 18 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Performance

SNPS stock opened at $478.97 on Tuesday. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a market cap of $91.64 billion, a price-to-earnings ratio of 59.95, a PEG ratio of 3.97 and a beta of 1.16. The business’s fifty day simple moving average is $438.09 and its two-hundred day simple moving average is $503.51. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period in the prior year, the business posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Baird R W downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Mizuho cut their target price on Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research report on Thursday, September 11th. The Goldman Sachs Group decreased their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, Morgan Stanley increased their target price on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Eleven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $562.13.

Read Our Latest Research Report on Synopsys

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.62% of the company’s stock.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.